Innovative strategies against superbugs: Developing an AI-CDSS for precise Stenotrophomonas maltophilia treatment.
Journal:
Journal of global antimicrobial resistance
PMID:
38909685
Abstract
OBJECTIVES: The World Health Organization named Stenotrophomonas maltophilia (SM) a critical multi-drug resistant threat, necessitating rapid diagnostic strategies. Traditional culturing methods require up to 96 h, including 72 h for bacterial growth, identification with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) through protein profile analysis, and 24 h for antibiotic susceptibility testing. In this study, we aimed at developing an artificial intelligence-clinical decision support system (AI-CDSS) by integrating MALDI-TOF MS and machine learning to quickly identify levofloxacin and trimethoprim/sulfamethoxazole resistance in SM, optimizing treatment decisions.
Authors
Keywords
Anti-Bacterial Agents
Artificial Intelligence
Decision Support Systems, Clinical
Drug Resistance, Multiple, Bacterial
Gram-Negative Bacterial Infections
Humans
Levofloxacin
Machine Learning
Microbial Sensitivity Tests
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Stenotrophomonas maltophilia
Trimethoprim, Sulfamethoxazole Drug Combination